000 01310 a2200385 4500
005 20250514162710.0
264 0 _c20040123
008 200401s 0 0 eng d
022 _a0007-1048
024 7 _a10.1046/j.1365-2141.2003.04697.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarypidou, Vasilia
245 0 0 _aEfficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes.
_h[electronic resource]
260 _bBritish journal of haematology
_cDec 2003
300 _a958 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAged
650 0 4 _aDrug Administration Schedule
650 0 4 _aErythropoietin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyelodysplastic Syndromes
_xtherapy
650 0 4 _aRecombinant Proteins
650 0 4 _aTreatment Outcome
700 1 _aVerrou, Evgenia
700 1 _aVakalopoulou, Sofia
700 1 _aPerifanis, Vasilios
700 1 _aTziomalos, Konstantinos
700 1 _aVenizelos, Ioannis
773 0 _tBritish journal of haematology
_gvol. 123
_gno. 5
_gp. 958
856 4 0 _uhttps://doi.org/10.1046/j.1365-2141.2003.04697.x
_zAvailable from publisher's website
999 _c14369062
_d14369062